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Materials and Methods: Standard 3D IMRT treatment plans were 
created for 10 NSCLC patients with lymph node involvement based on 
the mid-ventilation phase with a prescribed dose of 66Gy/33F. A CTV 
margin of 1 cm was used around the lymph nodes and was adjusted in 
order to exclude bone tissue and larger blood vessels. Patient-specific 
PTV margins of 0.7-1.0 cm were calculated using a probabilistic 
margin formula and were applied to the CTV. Random day-to-day 
variations of the baseline shift between the primary tumour and the 
CTV-node were simulated by blurring the dose distribution in either 
the cranial-caudal (CC), left-right (LR) or anterior-posterior (AP) 
directions with a Gaussian error distribution. Furthermore, a 
systematic shift between the lymph node and the primary tumour was 
simulated by displacing the dose distribution relative to the 
delineated structures with both 0.25 cm and 0.50 cm. Sufficient dose 
coverage of the involved lymph node was defined as the minimum 
dose (D98%) of the CTV-node was larger than 95% of the prescribed 
dose for 90% of the patients. 
Results: The figure shows the minimum dose of the CTV-node for 90% 
of the patients as a function of the random peak-to-peak variation in 
the CC direction for the different types of simulations. Dose coverage 
was sufficient for all data points above 95% of the prescribed dose, 
which is indicated by the dashed line in the figure. Table 1 
summarises the acceptable random peak-to-peak variations in the CC, 





Conclusions: Dose coverage of the CTV-node can be achieved with 
large random peak-to-peak variations between the primary tumour 
and CTV-node in treatments corrected for daily baseline shift of the 
primary tumour. With the introduction of a systematic shift during the 
treatment course the random peak-to-peak variation was only slightly 
reduced. However, large systematic shifts are undesirable and should 
justify a re-planning of the treatment. 
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Purpose/Objective: 3D position verification in breast radiotherapy 
with kV-CBCT is very accurate but time-consuming, especially in gated 
breast radiotherapy. Due to the need for uniform position verification 
in non-gated and gated conformal breast radiotherapy, the accuracy 
of the patient position adjustment based on the online matching of 
two orthogonal kV fields was investigated. 
Materials and Methods: Twenty breast cancer patients and 20 
patients treated for breast cancer in combination with internal 
mammary-medial supraclavicular (IMMS) lymph node irradiation, i.e. 
locoregional breast treatment, were included in the study. Each 
treatment was performed on a Varian Clinac 2100C/D linear 
accelerator equipped with an amorphous-silicon EPID and an OBI 
system (Varian Medical Systems, Inc.). The patient positioning and 
isocenter shift were checked with online paired kV-kV matching using 
the ribs close to the isocenter. One of the orthogonal kV fields was 
parallel to one of the tangential field directions (see figure). Only 
translations were adjusted. The new patient position was verified 
during 5 fractions by MV imaging of both tangential breast fields and 
kV imaging of the MS-field. All images were matched in Offline Review 
(Varian Medical Systems, Inc.) using bony anatomy. The differences 
for each tangential field were reported as ΔCLD (Central-Lung-
Distance, i.e. the distance between the deep field edge and the 
interior chest wall at field central axis), and ΔC(ranio)C(audal). The 
differences for the MS-field were reported as ΔVrt, i.e. ΔVertical, ΔCC 
and ΔLat(eral). The range of the patient mean errors, the percentage 
of the patient population with an absolute value of the mean error 
larger than 2mm, the population mean, population systematic error 
and population random error were reported. 
Results: For breast cancer treatment with and without IMMS 
irradiation, a mean CLD error ranging from -1mm to 2mm and from -
1mm to 3mm, respectively, was found. Only 5% of the breast cancer 
patients had a mean ΔCLD > 2mm. The patient mean ΔCC ranged from 
-3mm to 3mm and from 0mm to 3mm for the breast treatments and 
the locoregional breast treatments, respectively. For 10% of the 
patients, the mean ΔCC was larger than 2mm, irrespective of the 
treatment. None of the population systematic errors were larger than 
1mm and none of the population random errors were larger than 
2mm, irrespective of the patient group (see table). The population 
systematic and random errors measured in the MS-field were smaller 
than 1mm for all three directions (see table). 
 
 
Conclusions: The new position verification protocol is appropriate for 
accurate, uniform and quick 3D position verification in non-gated 
(locoregional) breast radiotherapy and easily extendible to gated 
breast radiotherapy. An important property of the protocol is the low 
imaging dose to both the target volume and the healthy tissue thanks 
to the combination of the kV imaging and the field orientation. 
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Purpose/Objective: Uncertainties in patient positioning are a crucial 
issue to be considered when treating patients with particles. In this 
study we aim to quantify the effect of small patient misalignment for 
different proton dose delivery techniques.  
Materials and Methods: We have investigatedthree different delivery 
techniques: 3D spot-scanning (3DSS), distal edge tracking(DET) and 
